$41.60
1.67% today
Nasdaq, Aug 12, 07:47 pm CET
ISIN
US30063P1057
Symbol
EXAS

Exact Sciences Corporation Stock price

$40.91
-11.00 21.19% 1M
-10.15 19.88% 6M
-15.28 27.19% YTD
-16.60 28.86% 1Y
-1.45 3.42% 3Y
-42.77 51.11% 5Y
+17.54 75.05% 10Y
+38.44 1,556.28% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.08 0.20%
ISIN
US30063P1057
Symbol
EXAS
Industry

Key metrics

Basic
Market capitalization
$7.7b
Enterprise Value
$9.2b
Net debt
$1.5b
Cash
$858.4m
Shares outstanding
189.2m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
2.6 | 2.4
EV/Sales
3.1 | 2.9
EV/FCF
74.0
P/B
3.1
Financial Health
Equity Ratio
40.5%
Return on Equity
-42.8%
ROCE
-2.9%
ROIC
-3.1%
Debt/Equity
0.9
Financials (TTM | estimate)
Revenue
$2.9b | $3.2b
EBITDA
$66.5m | $446.2m
EBIT
$-150.8m | $-93.1m
Net Income
$-1.0b | $-146.0m
Free Cash Flow
$124.6m
Growth (TTM | estimate)
Revenue
12.6% | 14.6%
EBITDA
175.1% | 365.4%
EBIT
16.9% | 48.1%
Net Income
-474.4% | 85.8%
Free Cash Flow
907.7%
Margin (TTM | estimate)
Gross
68.2%
EBITDA
2.3% | 14.1%
EBIT
-5.1%
Net
-34.2% | -4.6%
Free Cash Flow
4.2%
More
EPS
$-5.3
FCF per Share
$0.7
Short interest
4.5%
Employees
7k
Rev per Employee
$400.0k
Show more

Is Exact Sciences Corporation a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Exact Sciences Corporation Stock Analysis

Unlock Scores for Free

Analyst Opinions

33 Analysts have issued a Exact Sciences Corporation forecast:

29x Buy
88%
4x Hold
12%

Analyst Opinions

33 Analysts have issued a Exact Sciences Corporation forecast:

Buy
88%
Hold
12%

Financial data from Exact Sciences Corporation

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
2,940 2,940
13% 13%
100%
- Direct Costs 935 935
34% 34%
32%
2,005 2,005
5% 5%
68%
- Selling and Administrative Expenses 1,723 1,723
6% 6%
59%
- Research and Development Expense 414 414
10% 10%
14%
66 66
175% 175%
2%
- Depreciation and Amortization 217 217
134% 134%
7%
EBIT (Operating Income) EBIT -151 -151
17% 17%
-5%
Net Profit -1,005 -1,005
474% 474%
-34%

In millions USD.

Don't miss a Thing! We will send you all news about Exact Sciences Corporation directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Exact Sciences Corporation Stock News

Neutral
The Motley Fool
one day ago
Cathie Wood is one of the country's best known growth investors, but sometimes, she acts like an umbrella-toting value investor. The Ark Invest co-founder, CEO, and chief investment officer is often adding to some of her sinking positions on any given market day, and that's exactly what she did on the final trading day of last week.
Positive
Seeking Alpha
5 days ago
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divestiture of non-core assets, new leadership, and a focus on high-growth hospital monitoring technologies. Eli Lilly remains a core holding due to its leadership in diabetes and obesity treatments, robu...
Neutral
Seeking Alpha
6 days ago
Exact Sciences Corporation (NASDAQ:EXAS ) Q2 2025 Earnings Conference Call August 6, 2025 5:00 PM ET Company Participants Aaron Bloomer - Chief Financial Officer Derek Leckow - Vice President of Investor Relations Kevin T. Conroy - Chairman of the Board & CEO Conference Call Participants Andrew Frederick Brackmann - William Blair & Company L.L.C.
More Exact Sciences Corporation News

Company Profile

EXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI.

Head office United States
CEO Kevin Conroy
Employees 6,950
Founded 1995
Website www.exactsciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today